LON:BOYBodycote Share Price, Forecast & News

Bodycote's stock was trading at GBX 641 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BOY shares have decreased by 4.1% and is now trading at GBX 614.50. View which stocks have been most impacted by Coronavirus.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bodycote in the last year. There are currently 3 sell ratings, 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bodycote.

Bodycote PLC (LON:BOY) posted its quarterly earnings results on Tuesday, March, 6th. The company reported $49.20 earnings per share for the quarter, topping analysts' consensus estimates of $47.20 by $2.00. The business had revenue of $690.20 million for the quarter. View Bodycote's earnings history.

Bodycote announced a dividend on Thursday, March 12th. Investors of record on Thursday, April 23rd will be paid a dividend of GBX 14 per share on Friday, June 5th. This represents a dividend yield of 2.6%. The ex-dividend date of this dividend is Thursday, April 23rd. This is a boost from Bodycote's previous dividend of GBX 6. The official announcement can be viewed at this link. View Bodycote's dividend history.

13 equities research analysts have issued 12-month target prices for Bodycote's shares. Their forecasts range from GBX 520 to GBX 1,060. On average, they anticipate Bodycote's share price to reach GBX 683.08 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price. View analysts' price targets for Bodycote.

Press coverage about BOY stock has trended very negative recently, according to InfoTrie. The research firm ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Bodycote earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Bodycote.

Some companies that are related to Bodycote include Rheinmetall (RHM), IMI (IMI), Rotork (ROR), ATS Automation Tooling Systems (ATA), Krones (KRN), Pfeiffer Vacuum Technology (PFV), Duerr (DUE), Kuka (KU2), Stabilus (STM), Jungheinrich (JUN3), Morgan Advanced Materials (MGAM), Savaria (SIS), General Electric (GEC), PyroGenesis Canada (PYR) and Deutz (DEZ). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bodycote investors own include BTG (BTG), Indivior (INDV), Kenmare Resources (KMR), Diageo (DEO), AstraZeneca (AZN), Legal & General Group (LGEN), Lloyds Banking Group (LLOY), Meggitt (MGGT), Marks and Spencer Group (MKS) and NVIDIA (NVDA).

Bodycote trades on the London Stock Exchange (LON) under the ticker symbol "BOY."

Shares of BOY and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of BOY stock can currently be purchased for approximately GBX 614.50.

Bodycote has a market capitalization of £1.18 billion and generates £719.70 million in revenue each year. Bodycote employs 5,647 workers across the globe.

The official website for Bodycote is www.bodycote.com.

Bodycote's mailing address is Springwood Court, Springwood Close, MACCLESFIELD, SK10 2XF, United Kingdom. The company can be reached via phone at +44-1625-505300.